• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Lot Number 6LPEG19D
Device Problem No Apparent Adverse Event (3189)
Patient Problem Death (1802)
Event Date 09/18/2017
Event Type  Death  
Manufacturer Narrative
The model# was not provided.
 
Event Description
The (b)(6) received a medical devices adverse incident user report stating, on (b)(6) 2017, an individual received excessive insulin from the pump, resulting in brain injury due to hypoglycemia, followed by her death on (b)(6) 2017.The contour next link 2.4 was being used in conjunction with medtronic minimed 640g insulin pump.In summary, on (b)(6), midday, the customer was found at home in a comatose state.Paramedics were called and she was taken to (b)(6) hospital.Further details were not provided.Although, at no point was the meter mentioned as being implicated in the incident, the system has not been returned for evaluation.
 
Manufacturer Narrative
As the ascensia devices were lost by the courier company, we requested a copy of the analysis of the insulin pump data from medtronic, the insulin pump manufacturer.The contour next link 2.4 meter sends blood glucose results wirelessly to the pump.The last 3 readings sent to the pump (september 16th at 12:44, 14:28 and 15:59) were 3.6, 3.0 and 6.7mmol/l, which would not trigger an additional insulin bolus dose.This was followed by 2 manually entered blood glucose results of 12.6 and 13.7mmol/l at 16:16 and 16:57, respectively, which were significantly higher than the readings sent by the contour next link 2.4.As these readings were manually entered, they were most probably derived from an alternative monitoring system.From the pump data it can be established that no blood glucose results were entered on the day of the hypoglycemic event, nor were there any failed attempts to send results by the contour next link 2.4 on september 16th to the 18th.It would therefore appear that the contour next link 2.4 blood glucose system was not in use at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Type of Device
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
430 s beiger st
mishawaka IN 46544
Manufacturer (Section G)
ASCENSIA DIABETES CARE US INC
430 s beiger st
mishawaka IN 46544
Manufacturer Contact
jeri messmore
430 s beiger st
mishawaka, IN 46544
5743149617
MDR Report Key7122395
MDR Text Key95003903
Report Number1826988-2017-00354
Device Sequence Number1
Product Code NBW
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
P150001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/30/2018
Device Lot Number6LPEG19D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age39 YR
-
-